# Expanded Access to ANG1005 for Individual Patients

> **NCT02755987** · — · NO_LONGER_AVAILABLE · sponsor: **Angiochem Inc**

## Conditions studied

- Anaplastic Astrocytoma
- Anaplastic Oligodendroglioma
- Breast Cancer With Recurrent Brain Metastases
- Leptomeningeal Carcinomatosis

## Interventions

- **DRUG:** ANG1005

## Key facts

- **NCT ID:** NCT02755987
- **Lead sponsor:** Angiochem Inc
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** NO_LONGER_AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2016-06-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02755987

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02755987, "Expanded Access to ANG1005 for Individual Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02755987. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*